Sara Lonardi

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Sara Lonardi
Nov 30, 2024, 16:17 | Insight
Vivek Subbiah: The development of immunotherapy in MSI-H and D-MMR cancers by Thierry Andre et al.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Sep 24, 2024, 12:30 | Societies
11 ESMO24 presentations published on NEJM
At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…
Sep 17, 2024, 14:30 | Blog
Cathy Eng's highlights from ESMO24
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 10, 2024, 04:33 | Blog
Elias Karam: ACCENT pooled analysis published in JCO
Elias Karam, Hematology and Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn…
Sep 3, 2024, 13:11 | Insight
Julein Taieb: Real world evidence showing 50 MSI-H BRAF V600E mutant treated with immunotherapy
Julein Taieb, Professor, Paris Descartes University, shared a post on LinkedIn: "BRAFmutant, MSI, colorectal cancer…
Aug 7, 2024, 00:27 | Blog
Paolo Tarantino reflects on the results from DESTINY-CRC02 published in the Lancet Oncology
Paolo Tarantino shared on X: “Results from DESTINY-CRC02 published in the Lancet Oncology. Among patients…
Aug 5, 2024, 01:55 | Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Jul 29, 2024, 05:37 | Insight
Highlights in colorectal cancer at ASCO and ESMO GI 2024 by Video Journal of Oncology
David Tougeron, Professor at University of Poitiers Hospital, shared a post by Video Journal of…
Jul 2, 2024, 04:25 | OncoDaily Pulse
OncoDaily Party and Yvonne Award 2024 Photos - Part 2
On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…
Jun 21, 2024, 02:08 | Insight
New Paper Alert! AtezoTRIBE Study
AtezoTRIBE Study: Adding Atezolizumab to FOLFOXIRI/Bevacizumab Improves Survival in Metastatic Colorectal Cancer, Especially in Biomarker-Selected…
All: 10 Posts: 1 - 100
Special Coverage